Related Experiment Video
Updated: May 25, 2025
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
2.7K
Health Equity Intervention for Youth with Type 1 Diabetes and High Social Risk.
Stephanie M Stover-Kempers1, Kristen A Torres1, Samantha A Barry-Menkhaus1
1Department of Pediatrics, Oregon Health & Science University, Portland, OR 97239, USA.
Children (Basel, Switzerland)
|February 26, 2025
Summary
The Novel Interventions in Children's Healthcare (NICH) program significantly reduced hospital admissions and HbA1c levels in youth with type 1 diabetes (T1D). This study confirms NICH
Area of Science:
- Pediatric Endocrinology
- Diabetes Management
- Public Health Interventions
Background:
- Youth with type 1 diabetes (T1D) experiencing avoidable complications often have elevated HbA1c.
- The Novel Interventions in Children's Healthcare (NICH) program aims to improve outcomes in this population.
- Previous NICH outcome studies lacked a comparison group.
Purpose of the Study:
- To compare electronic health record (EHR) outcomes of NICH-enrolled youth with type 1 diabetes (T1D) to a control group.
- To evaluate the impact of the NICH program on HbA1c values and hospital utilization.
- To provide the first comparative analysis of NICH program effectiveness.
Main Methods:
- Retrospective EHR review of 101 youth with T1D and avoidable complications (NICH=40, comparison=61).
- Data included one year prior and two years post-NICH referral, focusing on HbA1c and hospitalizations.
- No significant demographic differences were found between the NICH and comparison groups.
Main Results:
- NICH youth showed significant reductions in mean admissions (1.55 to 0.99) and HbA1c (11.64% to 10.87%) post-referral.
- NICH participants had a lower proportion with HbA1c >10% compared to the control group at one year post-referral (p=0.03).
- ANOVA indicated a significantly greater reduction in admissions over time for NICH youth compared to the comparison group (p=0.047).
Conclusions:
- The NICH program led to significant improvements in health outcomes for youth with T1D.
- NICH participation resulted in reduced hospital admissions and lower HbA1c levels.
- This comparative study validates the effectiveness of the NICH intervention.
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
01:22Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
01:15Diabetes: Management and Pharmacotherapy
227
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
227
01:16Insulin: Dosing Regimen and Adverse Effects
137
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
137
01:15Diabetes: Symptoms, Diagnosis, and Complications
495
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
495
01:27Ethnic Identity within a Larger Culture
28
Adolescents from ethnic minority backgrounds face a multifaceted journey in forming their identities, shaped by the intersections of cultural expectations and personal exploration. For these adolescents, identity formation involves not only typical developmental challenges but also navigating the perceptions and attitudes of the majority culture. As they grow, adolescents in ethnic minority groups often become increasingly aware of stereotypes, social biases, and discrimination, all of which...
28